Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology

Abstract Background Chinese medicine Xuebijing (XBJ) has proven to be effective in the treatment of mild coronavirus disease 2019 (COVID-19) cases. But the bioactive compounds and potential mechanisms of XBJ for COVID-19 prevention and treatment are unclear. This study aimed to examine the potential...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:BioData Mining
المؤلفون الرئيسيون: Wen-jiang Zheng, Qian Yan, Yong-shi Ni, Shao-feng Zhan, Liu-liu Yang, Hong-fa Zhuang, Xiao-hong Liu, Yong Jiang
التنسيق: مقال
اللغة:الإنجليزية
منشور في: BMC 2020-10-01
الموضوعات:
Active ingredient
Coronavirus disease 2019
Effector mechanism
Molecular docking
Network pharmacology
Xuebijing
الوصول للمادة أونلاين:http://link.springer.com/article/10.1186/s13040-020-00227-6

الانترنت

http://link.springer.com/article/10.1186/s13040-020-00227-6

مواد مشابهة